Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal
Sun Pharmaceutical Industries Ltd. agreed to acquire New York-listed women’s health-care company Organon & Co., in what is likely to be one of the biggest India outbound deals in years.
ORIGINAL SOURCE →via Bloomberg Markets
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · US
- [CONFLICT] Trump says he is unaware if shooter planned to target him at Washington dinner event
- [CONFLICT] Celtics fans in the house with a loud "We Want Boston" chant.. people are starting to leave, so the chants will only get…
- [NATURAL] Avalanche 'weather' Kings' storm, complete sweep
- [FINANCE] Is the Vanguard Total Stock Market ETF the Best Buy for Long-Term Investors Right Now?
- [AVIATION] Major: American & United Airlines Cut 2,700 May Flights From The World's Busiest Airport
- [CONFLICT] Hürmüz savaşının 7 etkisi